Affiliation:
1. Department of Anatomy, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia
2. Department of Biological Sciences, School of Science and Technology, Sunway University, Selangor, Malaysia
Abstract
Parkinson’s Disease (PD) is one of the most common neurodegenerative disorders that affects
the motor system, and includes cardinal motor symptoms such as resting tremor, cogwheel rigidity,
bradykinesia and postural instability. Its prevalence is increasing worldwide due to the increase in
life span. Although, two centuries since the first description of the disease, no proper cure with regard
to treatment strategies and control of symptoms could be reached. One of the major challenges faced
by the researchers is to have a suitable research model. Rodents are the most common PD models
used, but no single model can replicate the true nature of PD. In this review, we aim to discuss another
animal model, the zebrafish (Danio rerio), which is gaining popularity. Zebrafish brain has all the major
structures found in the mammalian brain, with neurotransmitter systems, and it also possesses a
functional blood-brain barrier similar to humans. From the perspective of PD research, the zebrafish
possesses the ventral diencephalon, which is thought to be homologous to the mammalian substantia
nigra. We summarize the various zebrafish models available to study PD, namely chemical-induced
and genetic models. The zebrafish can complement the use of other animal models for the mechanistic
study of PD and help in the screening of new potential therapeutic compounds.
Funder
Universiti Kebangsaan Malaysia
Ministry of Higher Education, Malaysia
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,General Neuroscience
Reference147 articles.
1. Poewe W.; Seppi K.; Tanner C.M.; Parkinson disease. Nat Rev Dis Primers 2017,3,17013
2. Parkinson J.; An essay on the shaking palsy. J Neuropsychiatry Clin Neurosci 2002,14(2),223-236
3. McDonald C.; Gordon G.; Hand A.; Walker R.W.; Fisher J.M.; 200 Years of Parkinson’s disease: What have we learnt from James Parkinson? Age Ageing 2018,47(2),209-214
4. DeMaagd G.; Philip A.; Parkinson’s disease and its management: Part 1: Disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. P 2015,40(8),504-532
5. Marques de Sousa S.; Massano J.; Motor complications in Parkinson’s disease: A comprehensive review of emergent management strategies. CNS Neurol Disord Drug Targets 2013,12(7),1017-1049
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献